3-Methyl-5-oxo-5-(2-thienyl)valeric acid, 95.0%, 1g

7-Fluoro-6-nitro-4-hydroxyquinazoline, 95.0%, 100g

6-Fluoro-3-oxo-3,4-dihydropyrazine-2-carbonitrile compound with dicyclohexylamine (1:1), 98%, 250mg

2,6-Bis(trifluoromethyl)benzoic acid, 98.0%, 10g

b-(4-Hydroxyphenyl)ethyl iodoacetamide, 98.0%, 250mg

1-Benzylazepane, 95%, 250mg

6-(Difluoromethoxy)pyridine-3-carbonitrile, 95+%, 50mg

Anti-GT1a Monoclonal Antibody1vial

Methyl 3-(2-fluorophenyl)propanoate, 95.0%, 100g

N,N-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 5g

4-(2,5-dimethylphenyl)-5-propyl-1,3-thiazol-2-amine, 95.0%, 5g

(4-(n-(2-Hydroxyethyl)sulfamoyl)phenyl)boronic acid, 98%, 250mg

2-(Piperazin-1-yl)-5-(trifluoromethyl)pyrimidine dihydrochloride, 1g